Top Non-PVC IV Bags Companies

Non-PVC IV Bags Market size was valued at USD 1.92 Billion in 2024 and is poised to grow from USD 2.13 Billion in 2025 to USD 4.87 Billion by 2033, growing at a CAGR of 10.9% during the forecast period (2026–2033).

Global non-PVC IV bags market is relatively fragmented, with a high level of competition. Many businesses are putting an emphasis on organic growth initiatives, including new launches, product approvals, and others like patents and events. Acquisitions and partnerships & collaborations were two examples of inorganic growth tactics in the market. These actions have made it possible for market participants to grow their consumer bases and operations. With the increasing demand for non-PVC IV bags in the global industry, it is projected that market participants for non-PVC IV bags would have profitable growth prospects in the future.  'Baxter ', 'B. Braun Melsungen AG ', 'Pfizer, Inc. (Hospira) ', 'Fresenius Kabi AG ', 'JW Life Science ', 'RENOLIT ', 'PolyCine GmbH ', 'Sealed Air ', 'ANGIPLAST PVT. LTD ', 'Shanghai Solve Care Co Ltd. ', 'Kraton Corporation ', 'Jiangxi Sanxin Medtec Co., Ltd. ', 'Otsuka Pharmaceutical Co., Ltd ', 'Fresenius Kabi AG ', 'PolyCine GmbH'

Since chemotherapy involves administering drugs orally or intravenously (IV), factors such the rising cancer prevalence are anticipated to fuel market expansion throughout the forecast period. For instance, the World Health Organization (WHO) reports that cancer is the second biggest cause of death worldwide.

According to predictions, the use of ethylene vinyl acetate (EVA) in blood banks and the storage of frozen mixture will both expand in the next years. Additionally, as there are more blood banks globally, there is a growing need for storage of blood and blood components, which is growing both in awareness and demand. Due to a number of advantages such as chemical resistance, durability, clarity, and capacity to endure numerous sterilizing processes, the copolyester ether market is also expected to present a lucrative opportunity over the anticipated period.

North America held the largest share of the non-PVC IV bags market. The need for non-PVC IV containers, which can treat patients without endangering them, has surged in the United States as a result of stringent rules aimed at enhancing patient safety. Additionally, as the incidence of stomach cancer has grown over the past few years, so too has the demand for IV bags. For instance, according to the American Cancer Society, there will likely be 27,600 cases of stomach cancer diagnosed in the United States in 2020, which implies that 11,010 patients will pass away from the disease. Stomach cancer patients are unable to swallow food, thus they must fully rely on total parenteral nutrition to meet their nutritional needs and ensure their life.